Home » Topics » Regulatory » Patents

Patents
RSS

Roche patents novel D3/5-HT2A receptor ligands

Dec. 3, 2012

New TGR5 receptor agonists prepared by Bristol-Myers Squibb

Dec. 3, 2012

Researchers at Novartis synthesize new CYP17 inhibitors

Dec. 3, 2012

New hPASK/CK II inhibitors synthesized by Bioenergenix

Dec. 3, 2012

Japanese group divulges new antibacterial agents

Dec. 3, 2012

Novel protein kinase inhibitors patented by Abbott Laboratories

Nov. 30, 2012

Japan Tobacco designs novel RORgamma antagonists

Nov. 30, 2012

Shionogi & Co. presents new BACE1 inhibitors

Nov. 30, 2012

Exelixis prepares new iPFK2 inhibitors for cancer

Nov. 30, 2012

Novel PDE10 inhibitors disclosed by Mochida Pharmaceutical

Nov. 30, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...